Patents by Inventor Trudi S. Smith

Trudi S. Smith has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6870030
    Abstract: ASP2 polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing ASP2 polypeptides and polynucleotides in the design of protocols for the treatment of Alzheimer's Disease, cancer, and prohormone processing, among others, and diagnostic assays for such conditions.
    Type: Grant
    Filed: October 3, 2001
    Date of Patent: March 22, 2005
    Assignees: Smithkline Beecham Corporation, Smithkline Beecham plc
    Inventors: David J. Powell, Conrad G. Chapman, Kay Murphy, Trudi S. Smith
  • Publication number: 20030109022
    Abstract: ASP2 polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing ASP2 polypeptides and polynucleotides in the design of protocols for the treatment of Alzheimer's Disease, cancer, and prohormone processing, among others, and diagnostic assays for such conditions.
    Type: Application
    Filed: December 3, 2002
    Publication date: June 12, 2003
    Applicant: SmithKline Beecham Corporation
    Inventors: David J. Powell, Conrad G. Chapman, Kay Murphy, Trudi S. Smith
  • Publication number: 20030036112
    Abstract: ASP2 polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing ASP2 polypeptides and polynucleotides in the design of protocols for the treatment of AlzheiMer's Disease, cancer, and prohormone processing, among others, and diagnostic assays for such conditions.
    Type: Application
    Filed: October 3, 2001
    Publication date: February 20, 2003
    Inventors: David J. Powell, Conrad G. Chapman, Kay Murphy, Trudi S. Smith
  • Patent number: 6319689
    Abstract: ASP2 polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing ASP2 polypeptides and polynucleotides in the design of protocols for the treatment of Alzheimer's Disease, cancer, and prohormone processing, among others, and diagnostic assays for such conditions.
    Type: Grant
    Filed: January 20, 1998
    Date of Patent: November 20, 2001
    Assignees: SmithKline Beecham Corporation, SmithKline Beecham plc
    Inventors: David J Powell, Conrad G Chapman, Kay Murphy, Trudi S Smith